Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT07721467

1 development in the corpus

NCT07721467

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 7, 2026 · PHASE 2 TRIAL

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin

ClinicalTrials.gov

This is a Phase 2 interventional study registration with no reported results; it describes a planned trial of psilocybin combined with cognitive training in older adults with cognitive impairment, currently in pre-recruitment status.

PreliminaryNCT07721467 Alzheimer's Disease Cognitive Training

Reported

Planned enrollment200

Phase2

Primary outcome measureNeuroplasticity Composite Score (NPCS) at 4…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support